Clarifies on News item
With reference to news appeared in ET NOW dated April 12, 2017. "Jubilant Life to acquire cancer & body imaging company in US. Acquisition to be done via unit Jubilant Draximage Inc", Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Jubilant Life Sciences Ltd
The Exchange has sought clarification from Jubilant Life Sciences Ltd on April 12, 2017, with reference to news appeared in ET NOW dated April 12, 2017. "Jubilant Life to acquire cancer & body imaging company in US. Acquisition to be done via unit Jubilant Draximage Inc".The reply is awaited. Statement Of Investor Complaints For The Quarter Ended March 31, 2017
Statement of Investor Complaints for the Quarter ended March 31, 2017 Compliance Certificate For The Period Ended March 31, 2017
Sub.: Compliance Certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we certify that M/s Alankit Assignments Limited, a Category-I Registrar and Share Transfer Agent, registered with the Securities and...
Jubilant Life gets USFDA nod for arthritis drug
Jubilant Life Sciences has received final approval from the US health regulator for Celecoxib capsules used for the treatment of osteoarthritis and rheumatoid arthritis Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Consumer Pvt Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Consumer Pvt Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mav Management Advisors LLP